Vandana Chauhan

Vandana Chauhan is a strategic leader in Global Biopharmaceutical Chemistry, Manufacturing, and Controls (CMC) Regulatory with over 15 years of experience. Currently serving as the Head of CMC Biologics Regulatory Affairs at Gilead Sciences, Vandana previously held multiple leadership roles at Graphite Bio and Genentech, including Vice President of CMC Regulatory and Supply Chain, and Global Head of Pharma Technical Innovation Strategy. Vandana's expertise extends to leading cross-functional teams, developing regulatory strategies for new products and lifecycle management, and overseeing global submission strategies across various markets. Prior to this, Vandana held key positions at Roche, contributing to international regulatory approvals and strategies. Vandana holds a Master's degree in Immunology and a Bachelor's degree in Microbiology from the University of Arizona.